510(k) Report

510(k) · Cleared

Cleared

Access Toxo Igg Assay on the Access Immunoassay System

K951495510(k) TraditionalCleared Dec 20, 1995264-day reviewClass II21 CFR 866.3780

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad Laboratories, Inc. · LGD Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii

Cleared on Dec 20, 1995 after a 264-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 3 later devices descend from it.

Decided
Dec 20, 1995
Review
264 days
Class
Class II
Product code
LGD
Recalls
None
Predicates
0

3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2003: 1 descendant cleared2008: 1 descendant cleared2025: 1 descendant cleared1995200020052010201520202025
  1. This deviceK951495 Access Toxo Igg Assay on the Access Immunoassay SystemBio-Rad Laboratories, Inc. · 1995
  2. Descendant · cites it directly · 2 of its ownK032162 Access Immunoassay System Toxo Igg AssayBeckman Coulter, Inc. · 2003
  3. Descendant · cites it directly · 1 of its ownK080869 Access Toxo Igg, Access Toxo Igg Calibrators and Access Toxo Igg QCBeckman Coulter, Inc. · 2008
  4. Descendant · 2 generations on · 0 of its ownK242022 Access Toxo IgGBeckman Coulter, Inc. · 2025

Most influential descendants

Showing 3 of 3 · See all
  • K032162Access Immunoassay System Toxo Igg AssayBeckman Coulter, Inc. · 2003 · cites it directly2descendants
  • K080869Access Toxo Igg, Access Toxo Igg Calibrators and Access Toxo Igg QCBeckman Coulter, Inc. · 2008 · cites it directly1descendant
  • K242022Access Toxo IgGBeckman Coulter, Inc. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K951495Access Toxo Igg Assay on the Access Immunoassay SystemBio-Rad Laboratories, Inc.1995—
+1K032162Access Immunoassay System Toxo Igg AssayBeckman Coulter, Inc.2003—
+1K080869Access Toxo Igg, Access Toxo Igg Calibrators and Access Toxo Igg QCBeckman Coulter, Inc.2008—
+2K242022Access Toxo IgGBeckman Coulter, Inc.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200810
202510
FIG. 1 — Lineage of K951495, 1995–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LGD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LGD device

  1. #1 K242022 Access Toxo IgGscore 9.7 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K032162Access Immunoassay System Toxo Igg AssayBeckman Coulter, Inc.20032
K080869Access Toxo Igg, Access Toxo Igg Calibrators and Access Toxo Igg QCBeckman Coulter, Inc.20081

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K032162 (Beckman Coulter, Inc., 2003) has gone furthest, with 2 descendants of its own.

How does its category compare?

All LGD devices

LGD Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LGD

1in 2025

2008: 22009: 12011: 22013: 22015: 12017: 12022: 12024: 22025: 1
2007high 2 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LGD

Too few LGD 510(k)s in any year since 2007 to give a median.

Recalls per year · LGD

1in 2021

2007: 22008: 12010: 12021: 1
2007high 2 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LGD

89in 2025

2007: 42008: 142009: 912010: 712011: 1152012: 752013: 352014: 222015: 1212016: 1402017: 1732018: 1002019: 592020: 872021: 382022: 732023: 1182024: 812025: 89
2007high 173 (2017) · low 4 (2007)2025

MAUDE reports naming product code LGD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—24
20082—114
20091—091
20100—171
20112—0115
20120—075
20132—035
20140—022
20151—0121
20160—0140
20171—0173
20180—0100
20190—059
20200—087
20210—138
20221—073
20230—0118
20242—081
20251—089
20260—0—
Cite this page

510(k) Report. “K951495: Access Toxo Igg Assay on the Access Immunoassay System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K951495

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026